Prognostic Information From Endocardial Voltage Mapping at the Time of Endomyocardial Biopsy for the Diagnosis of Cardiac Amyloidosis
Authors:
- 28 December 2023
- journal article
- editorial
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 40 (3) , 385-387
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart AssociationCirculation, 2020
- Long-Term Arrhythmic Risk Assessment in Biopsy-Proven MyocarditisJACC: Clinical Electrophysiology, 2020
- Natural History, Quality of Life, and Outcome in Cardiac Transthyretin AmyloidosisCirculation, 2019
- Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging SystemJACC, 2016
- Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathyHeart Rhythm, 2016
- Patient experience with hereditary and senile systemic amyloidoses: a survey from the Amyloidosis Research ConsortiumOrphanet Journal of Rare Diseases, 2015
- Prognostic Value of Endocardial Voltage Mapping in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/DysplasiaCirculation: Arrhythmia and Electrophysiology, 2013
- Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract EpicardiumCirculation, 2011
- Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic AmyloidosisJournal of Clinical Oncology, 2004
- Electrophysiologic Abnormalities in AL (Primary) Amyloidosis With Cardiac InvolvementJACC, 1997